PharmNovo Revenue

Biotechnology Research • Lund, Skåne County, Sweden • 1-10 Employees

PharmNovo revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	$18,971,900

Key Contact at PharmNovo

Bengt Von Mentzer

Chief Scientific Advisor, Founder

Company overview

Headquarters	Lund, Skåne County, Sweden
Phone number	+46705443250
Website	pharmnovo.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Neurology, Pharmacology, Chemistry, Bioscience, CNS, Proteins, Biopharma, Chronic Pain Treatment, Dor Agonists, Delta Opioid Receptor
Founded	2008
Employees	1-10
Socials

PharmNovo Email Formats

PharmNovo uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@pharmnovo.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@pharmnovo.com	100%

About PharmNovo

PharmNovo AB is a clinical-stage pharmaceutical company focused on developing safe and effective drugs for neuropathic pain. In this area, there is currently a lack of sufficient treatments. The company’s drug candidate, PN6047, effectively reduces neuropathic pain in animal models and the findings from the Phase I trial show that PN6047 is safe and well-tolerated at the doses tested, with no serious adverse events reported. Furthermore, PN6047 exhibited none of the adverse events typically associated with the conventional opioids like oxycodone and morphine, such as respiratory depression, constipation, itching, or signs of abuse potential. This validates the unique preclinical profile of PN6047, which shows that it acts extremely selectively on the delta opioid receptor distinguishing it fundamentally from conventional opioids that target the mu opioid receptor. PN6047 is Phase II ready!

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Founder/Owner

Employees by Department

PharmNovo has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore PharmNovo's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-08-15	4	$571,900
2023-10-26	1	$2,100,000
2024-08-15	1	$16,300,000

Funding Insights

$18,971,900

Total funding amount

$16,300,000

Most recent funding amount

Number of funding rounds

PharmNovo Tech Stack

Discover the technologies and tools that power PharmNovo's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Lucide

Font scripts

core-js

JavaScript libraries

Webflow

Page builders

Google Analytics

Analytics

One.com

Hosting

Frequently asked questions

PharmNovo is located in Lund, Skåne County, SE.

You can reach PharmNovo at +46705443250.

PharmNovo generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

PharmNovo has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

PharmNovo was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

PharmNovo has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

PharmNovo has raised a total of $18,971,900 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at PharmNovo

Bengt Von Mentzer

Chief Scientific Advisor, Founder

4.8

40,000 users